EPS Diluted (Annual) Chart

Historical EPS Diluted (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
September 30, 2025 -1.219
September 30, 2024 -3.101
September 30, 2023 -0.2152
September 30, 2022 -5.727
September 30, 2021 1.487
September 30, 2020 0.8782
September 30, 2019 0.3981
September 30, 2018 1.643
September 30, 2017 0.8883
September 30, 2016 -1.01
September 30, 2015 0.21
September 30, 2014 0.066
September 30, 2013 -0.03
September 30, 2012 2.08
September 30, 2011 1.97
September 30, 2010 0.92
Date Value
September 30, 2009 -3.62
September 30, 2008 -3.666
September 30, 2007 0.9122
September 30, 2006 0.36
September 30, 2005 -0.18
September 30, 2004 0.63
September 30, 2003 -5.05
September 30, 2002 -27.90
September 30, 2001 -1.65
September 30, 2000 0.78
September 30, 1999 -0.76
September 30, 1998 -1.84
September 30, 1997 0.00
September 30, 1996 0.00
September 30, 1995 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Agilent Technologies, Inc. 4.572
Bio-Rad Laboratories, Inc. 27.85
Bruker Corp. -0.1482
Danaher Corp. 5.047
Harvard Bioscience, Inc. -12.77